Postpartum Depression (PPD)

Neurology
0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

City Therapeutics
City TherapeuticsMA - Cambridge
1 program
LHMoms InterventionN/A1 trial
Active Trials
NCT06666400Active Not RecruitingEst. Jun 2030
Magnus Medical
Magnus MedicalCA - Burlingame
1 program
SAINT Neuromodulation SystemN/A1 trial
Active Trials
NCT07210255RecruitingEst. Oct 2029

Trial Timeline

Clinical trial activity over time

2025
2026
2027
2028
2029
2030
Magnus MedicalSAINT Neuromodulation System
City TherapeuticsLHMoms Intervention

Clinical Trials (2)

NCT07210255Magnus MedicalSAINT Neuromodulation System

SAINT in Postpartum Depression (PPD)

Start: Nov 2025Est. completion: Oct 2029
N/ARecruiting
NCT06666400City TherapeuticsLHMoms Intervention

Living Healthy for Moms RCT

Start: Jan 2025Est. completion: Jun 2030
N/AActive Not Recruiting

Related Jobs in Neurology

Director, Distribution & Services

Xenon Pharmaceuticals
Remote
8h ago

Senior Medical Science Liaison (NYC Tri-State)

Xenon Pharmaceuticals
Remote
8h ago
$208K - $234K/yr

Director of Medical Affairs

CoMind
Miami, FL
9h ago

Director of Finance

CoMind
London, UK
9h ago

Electronics Engineering Manager

CoMind
London, UK
9h ago

Director of Information Technology

Zavation Medical Products
9h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials
2 companies competing in this space

Related Indications

Multiple Sclerosis(274)Schizophrenia(255)Epilepsy(242)Parkinson Disease(171)Alzheimer's Disease(165)Parkinson's Disease(160)Alzheimer Disease(117)Stroke(102)Relapsing-Remitting Multiple Sclerosis(83)Depression(82)